Patients’ characteristics at inclusion.

<p>Patients’ characteristics at inclusion.</p

Analysis of factors associated with early cardiovascular events after kidney transplantation in univariate analysis.

<p>Immunosuppressive regimen: <b>LIR = Low immunological risk</b> = Immunosuppressive therapy, included a combination of anti-CD25 (Basiliximab) 20mg at day 0 and 4, steroids 500mg at day 0, 125mg at day 1 then rapidly tapered to 10mg per day, calcineurin inhibitors (cyclosporine or tacrolimus) and antimetabolites; <b>HIR = High immunological risk</b> (immunized patients) = immunosuppressive therapy included induction with thymoglobulin (1.5mg/kg/day for five days), steroids 500mg at day 0, 125mg at day 1 then rapidly tapered to 10mg per day, calcineurin inhibitors (cyclosporine or tacrolimus), antimetabolites, intravenous immunoglobulin (four courses of 2g/kg).</p><p>^aFor an increase of 5 units</p><p>^bFor an increase of 1 unit</p><p>^cFor an increase of 10 units</p><p>Analysis of factors associated with early cardiovascular events after kidney transplantation in univariate analysis.</p

Screening strategy for cardiovascular disease before transplantation.

<p>Screening strategy for cardiovascular disease before transplantation.</p

Pre-transplant cardiovascular evaluation and results.

<p>All renal transplant recipients underwent electrocardiography, echocardiography and non-invasive testing.</p><p>Pre-transplant cardiovascular evaluation and results.</p